The type I IFN system in rheumatoid arthritis

References

• McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007; 7 6: 429–442.
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Roth J. Mechanisms of disease: A ‘DAMP’ view of inflammatory arthritis. Nat Clin Pract Rheumatol. 2007; 3 7: 382–390.
   PubMedGoogle Scholar
• Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol. 2002; 2 5: 364–371.
   PubMed Web of Science ®Google Scholar
• Goronzy JJ, Weyand CM. T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol. 2004; 16 3: 212–217.
   PubMed Web of Science ®Google Scholar
• Webb LM, Walmsley MJ, Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2. Eur J Immunol. 1996; 26 10: 2320–2328.
   PubMed Web of Science ®Google Scholar
• Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S, Russell A, Dougados M, Emery P, Nuamah IF, Williams GR, Becker JC, Hagerty DT, Moreland LW. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med. 2003; 349 20: 1907–1915.
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 2006; 54 2: 408–420.
   Google Scholar
• Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ. Characterization of the type I interferon locus and identification of novel genes. Genomics. 2004; 84 2: 331–345.
   Google Scholar
• Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999; 284 5421: 1835–1837.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004; 4:499–511.
   PubMed Web of Science ®Google Scholar
• Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med. 2007; 13 5: 543–551.
   Google Scholar
• Platanias LC. Mechanisms of type-I and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5 5: 375–386.
   PubMed Web of Science ®Google Scholar
• Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc Roy Soc Lond B Biol Sci. 1957; 147 927: 258–267.
   PubMed Web of Science ®Google Scholar
• Fitzgerald-Bocarsly P, Feng D. The role of type I interferon production by dendritic cells in host defense. Biochimie. 2007; 89 6-7: 843–855.
   Google Scholar
• Vremec D, O'Keeffe M, Hochrein H, Fuchsberger M, Caminschi I, Lahoud M, Shortman K. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood. 2007; 109 3: 1165–1173.
   Google Scholar
• Reis e Sousa C. Dendritic cells in a mature age. Nat Rev Immunol. 2006; 6 6: 476–483 (Review).
   PubMed Web of Science ®Google Scholar
• Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol. 1998; 161 4: 1947–1953.
   PubMed Web of Science ®Google Scholar
• Hibbert L, Pflanz S, De Waal Malefyt R, Kastelein RA. IL-27 and IFN-α signal via Stat1 and Stat3 and induce T-Bet and IL-12Rβ2 in naive T cells. J Interferon Cytokine Res. 2003; 23:513–522.
   PubMed Web of Science ®Google Scholar
• Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med. 2005; 202 5: 637–650 Epub 2005 Aug 29–[].
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Baccala R, Beutler B, Kono DH. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005; 23:307–336.
   PubMed Web of Science ®Google Scholar
• Rönnblom L, Pascual V. The innate immune system in SLE: Type I interferons and dendritic cells. Lupus. 2008; 17 5: 394–399.
   PubMed Web of Science ®Google Scholar
• Pettit AR, Thomas R. Dendritic cells: The driving force behind autoimmunity in rheumatoid arthritis?. Immunol Cell Biol. 1999; 77 5: 420–427 Review.
   Google Scholar
• Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL. Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979; 301 1: 5–8.
   PubMed Web of Science ®Google Scholar
• Shiozawa S, Chihara K, Shiozawa K, Fujita T, Ikegami H, Koyama S, Kurimoto M. A sensitive radioimmunoassay for alpha-interferon: Circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients. Clin Exp Immunol. 1986; 66 1: 77–87.
   Google Scholar
• Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol. 1988; 73 1: 88–92.
   Google Scholar
• Fong KY, Boey ML, Koh WH, Feng PH. Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: Correlation with bony erosions. Clin Exp Rheumatol. 1994; 12 1: 55–58.
   Google Scholar
• Gattorno M, Chicha L, Gregorio A, Ferlito F, Rossi F, Jarrossay D, Lanzavecchia A, Martini A, Manz MG. Distinct expression pattern of IFN-alpha and TNF-alpha in juvenile idiopathic arthritis synovial tissue. Rheumatology (Oxford). 2007; 46 4: 657–665.
   Google Scholar
• Han SW, Lee WK, Kwon KT, Lee BK, Nam EJ, Kim GW. Association of polymorphisms in interferon regulatory factor 5 gene with rheumatoid arthritis: A metaanalysis. J Rheumatol. 2009; 36 4: 693–697.
   Google Scholar
• Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L, Toes R, Rönnelid J, Klareskog L, Huizinga TW, Alm G, Syvänen AC, Rönnblom L. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 2007; 56 7: 2202–2210.
   Google Scholar
• Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, de Bakker PI, Le JM, Lee HS, Batliwalla F, Li W, Masters SL, Booty MG, Carulli JP, Padyukov L, Alfredsson L, Klareskog L, Chen WV, Amos CI, Criswell LA, Seldin MF, Kastner DL, Gregersen PK. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007; 357 10: 977–986.
   PubMed Web of Science ®Google Scholar
• Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H, O'Shea JJ. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol. 2000; 164 9: 4659–4664.
   PubMed Web of Science ®Google Scholar
• Thomas R, Quinn C. Functional differentiation of dendritic cells in rheumatoid arthritis: Role of CD86 in the synovium. J Immunol. 1996; 156 8: 3074–3086.
   Google Scholar
• Thomas R, Lipsky PE. Presentation of self peptides by dendritic cells: Possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum. 1996; 39 2: 183–190.
   PubMed Web of Science ®Google Scholar
• Van Krinks CH, Matyszak MK, Gaston JS. Characterization of plasmacytoid dendritic cells in inflammatory arthritis synovial fluid. Rheumatology (Oxford). 2004; 43 4: 453–460.
   Google Scholar
• Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA. 2005; 102 9: 3372–3377.
   PubMed Web of Science ®Google Scholar
• Lebre MC, Jongbloed SL, Tas SW, Smeets TJ, McInnes IB, Tak PP. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP-dendritic cells with distinct cytokine profiles. Am J Pathol. 2008; 172 4: 940–950.
   Google Scholar
• McRae BL, Semnani RT, Hayes MP, van Seventer GA. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J Immunol. 1998; 160 9: 4298–4304.
   Google Scholar
• Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, Blazar BR, Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol. 2004; 173 7: 4433–4442.
   PubMed Web of Science ®Google Scholar
• Roelofs MF, Wenink MH, Brentano F, Abdollahi-Roodsaz S, Oppers-Walgreen B, Barrera P, van Riel PL, Joosten LA, Kyburz D, van den Berg WB, Radstake TR. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4 mediated synovial inflammation in rheumatoid arthritis (RA). Ann Rheum Dis. 2009; 68 9: 1486–1493.
   PubMed Web of Science ®Google Scholar
• Wong T, Majchrzak B, Bogoch E, Keystone EC, Fish EN. Therapeutic implications for interferon-alpha in arthritis: A pilot study. J Rheumatol. 2003; 30 5: 934–940.
   Google Scholar
• Niewold TB, Gibofsky A. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C. Arthritis Rheum. 2006; 54 7: 2335–2337.
   Google Scholar
• Passos de Souza E, Evangelista Segundo PT, José FF, Lemaire D, Santiago M. Rheumatoid arthritis induced by alpha-interferon therapy. Clin Rheumatol. 2001; 20 4: 297–299.
   Google Scholar
• Nadir F, Fagiuoli S, Wright HI, Nadir A, Hopp E, Gavaler J, Van Thiel DH. Rheumatoid arthritis: A complication of interferon therapy. J Okla State Med Assoc. 1994; 87 5: 228–230.
   PubMedGoogle Scholar
• Vervoordeldonk MJ, Aalbers CJ, Tak PP. Interferon beta for rheumatoid arthritis: New clothes for an old kid on the block. Ann Rheum Dis. 2009; 68 2: 157–158.
   Google Scholar
• Smeets TJ, Dayer JM, Kraan MC, Versendaal J, Chicheportiche R, Breedveld FC, Tak PP. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum. 2000; 43 2: 270–274.
   PubMed Web of Science ®Google Scholar
• van Holten J, Smeets TJ, Blankert P, Tak PP. Expression of interferon beta in synovial tissue from patients with rheumatoid arthritis: Comparison with patients with osteoarthritis and reactive arthritis. Ann Rheum Dis. 2005; 64 12: 1780–1782.
   PubMed Web of Science ®Google Scholar
• Coclet-Ninin J, Dayer JM, Burger D. Interferon-beta not only inhibits interleukin-1beta and tumor necrosis factor-alpha but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur Cytokine Netw. 1997; 8 4: 345–349.
   PubMed Web of Science ®Google Scholar
• van Holten J, Reedquist K, Sattonet-Roche P, Smeets TJ, Plater-Zyberk C, Vervoordeldonk MJ, Tak PP. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res Ther. 2004; 6 3: R239–R249.
   PubMed Web of Science ®Google Scholar
• Triantaphyllopoulos KA, Williams RO, Tailor H, Chernajovsky Y. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy. Arthritis Rheum. 1999; 42 1: 90–99.
   PubMedGoogle Scholar
• Tak PP, Hart BA, Kraan MC, Jonker M, Smeets TJ, Breedveld FC. The effects of interferon beta treatment on arthritis. Rheumatology (Oxford). 1999; 38 4: 362–369.
   Google Scholar
• Bailey-Bucktrout SL, Caulkins SC, Goings G, Fischer JA, Dzionek A, Miller SD. Cutting edge: Central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J Immunol. 2008; 180 10: 6457–6461.
   PubMed Web of Science ®Google Scholar
• Jongbloed SL, Benson RA, Nickdel MB, Garside P, McInnes IB, Brewer JM. Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol. 2009; 182 2: 963–968.
   Web of Science ®Google Scholar
• Maffia P, Brewer JM, Gracie JA, Ianaro A, Leung BP, Mitchell PJ, Smith KM, McInnes IB, Garside P. Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells. J Immunol. 2004; 173 1: 151–156.
   Google Scholar
• Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science. 1990; 250 4988: 1720–1723.
   Google Scholar
• Smith KM, Pottage L, Thomas ER, Leishman AJ, Doig TN, Xu D, Liew FY, Garside P. Th1 and Th2 CD4+T cells provide help for B cell clonal expansion and antibody synthesis in a similar manner in vivo. J Immunol. 2000; 165 6: 3136–3144.
   Google Scholar
• Nickdel MB, Conigliaro P, Valesini G, Hutchison S, Benson R, Bundick RV, Leishman AJ, McInnes IB, Brewer JM, Garside P. Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis. Ann Rheum Dis. 2009; 68 6: 1059–1066.
   Google Scholar
• Asselin-Paturel C, Brizard G, Pin JJ, Brière F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol. 2003; 171 12: 6466–6477.
   Google Scholar
• Speziani C, Rivollier A, Gallois A, Coury F, Mazzorana M, Azocar O, Flacher M, Bella C, Tebib J, Jurdic P, Rabourdin-Combe C, Delprat C. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol. 2007; 37 3: 747–757.
   PubMed Web of Science ®Google Scholar
• Schwarz EM, Looney RJ, Drissi MH, O'Keefe RJ, Boyce BF, Xing L, Ritchlin CT. Autoimmunity and bone. Ann N Y Acad Sci. 2006; 1068:275–283.
   Google Scholar
• van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE. Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol. 2007; 179 3: 1506–1515.
   PubMed Web of Science ®Google Scholar
• van Duivenvoorde LM, Louis-Plence P, Apparailly F, van der Voort EI, Huizinga TW, Jorgensen C, Toes RE. Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells. Arthritis Rheum. 2004; 50 10: 3354–3364.
   Google Scholar